5/18
Coronavirus Research
You think you have long COVID: What now?
Penn Medicine’s long COVID clinic assists patients with an array of symptoms including persistent fatigue, difficulty breathing, insomnia, and “brain fog.”
Guaranteed income improved people’s health during the pandemic
Associate professor Amy Castro of the School of Social Policy & Practice shares the final results from the Stockton pilot program, which show connections between financial security and better health.
How have women in the workforce fared, three years into the pandemic?
Despite hopeful signs that this demographic is returning to work, certain female-dominated sectors, like the care economy, still haven’t recovered, signaling there’s more to learn about COVID-19’s full effect.
States with high COVID-19 death rates also saw high mortality from other causes
Research from Penn, Boston University, and the Robert Wood Johnson Foundation shows that between March 2020 and February 2021 non-COVID deaths accounted for some 20% of excess mortality.
What statistics are most likely to promote positive actions during a pandemic?
A new study from PIK Professor Dolores Albarracín and research associate Haesung Annie Jung finds that some COVID statistics are more effective than others at encouraging people to change their behavior.
Flu vaccination rate holds but misinformation about flu and COVID persists
The latest Annenberg Science Knowledge survey by the Annenberg Public Policy Center highlights continuing uncertainty about consequential information about the flu, COVID-19, and vaccination.
Why COVID misinformation continues to spread
Penn Medicine’s Anish Agarwal discusses why false claims about the virus and vaccines arise and persist, plus what he hopes will come from NIH-funded research he and Penn Engineering’s Sharath Chandra Guntuku have recently begun.
Five things to know about this year’s ‘tripledemic’
The Perelman School of Medicine’s E. John Wherry and Scott Hensley discuss the season’s confluence of COVID-19, influenza, and RSV and how our bodies are responding.
How sex differences may influence lung injury
Comparing lung cells from male and female mice, School of Veterinary Medicine scientists found gene expression differences that may explain why older males are at a higher risk than females for worse outcomes from COVID-19 and similar diseases.
Our 15 favorite stories from 2022
From interdisciplinary research and life-changing discoveries to a new University president and everything in between, this year at Penn has been one for the books.
In the News
The mRNA miracle workers
Nobel laureates Katalin Karikó and Drew Weissman of the Perelman School of Medicine appear on “Sunday Morning” to discuss their careers, their mRNA research, and the COVID-19 vaccines.
FULL STORY →
Review of COVID death stats finds likely undercount in official numbers
A paper co-authored by Penn researchers found that COVID-19 deaths in the U.S. were likely undercounted in official statistics during the first 30 months of the pandemic.
FULL STORY →
The Franklin Institute honors nine scientists and engineers on its 200th anniversary
Katalin Karikó and Drew Weissman of the Perelman School of Medicine are noted for receiving awards from the Franklin Institute and subsequently being honored with a Nobel Prize.
FULL STORY →
You should still get the COVID-19 vaccine. The Nobel Prize winner who helped discover it explains why
Drew Weissman of the Perelman School of Medicine, who won the Nobel Prize along with Katalin Karikó, discusses the backlash against vaccinations and whether to receive the latest COVID vaccine.
FULL STORY →
Long COVID brain fog may originate in a surprising place, say scientists
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues finds that long COVID’s neurological symptoms, like brain fog, memory loss, and fatigue, may stem from serotonin reduction.
FULL STORY →
Long COVID research is in its ‘most hopeful’ phase yet
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues suggests that serotonin could be a target for long COVID treatment.
FULL STORY →